Drug Trial Radar · NCT01168375
The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy
Last checked: Nov 20, 2026Latest source record: Jul 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Shahid Beheshti University of Medical SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ophthalmic Research Center
- First posted
- Jul 23, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
80 diabetic patients underwent vitrectomy and had no history of Eye herpes infection, Refractive surgery, Autoimmune disease, Immune deficiency will be randomized into two groups (double blind)to evaluate the role of umbilical cord serum therapy on improvement of corneal epithelial defect following diabetic vitrectomy. Both groups will take the conventional medication including Chloramphenicol, Betamethasone, Cycloplegic eye drops besides the case group will take umbilical cord serum eye drop in the eye operated. After surgery the corneal epithelial defect will be measured by slit lamp.
Conditions
- Corneal Epithelial Defect
Interventions
conventional therapy plus umbilical cord serum eye dropDrug
chloramphenicol and betamethasone eye drops every 6 hours, cycloplegic (homatropine) eye drop every 8 hours plus umbilical cord serum eye drop 20% every 4 hours
conventional therapyDrug
chloramphenicol and betamethasone eye drops every 6 hours, cycloplegic (homatropine) eye drop every 8 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- measurement of corneal epithelial defect
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ophthalmic Research Center
Tehran, Tehran Province, Iran
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.